Adverse Event Reporting

VAERS ID 1668042
Gender Female
Age
StateCode FR
Pharmaceutical Company PFIZER\BIONTECH
Lot Number FE1573
Number of vaccinations 1
Vaccinated 2021-07-29
Onset 2021-07-30
Condition
Symptoms
  • SARS-CoV-2 test
  • Uterine haemorrhage
  • Heavy menstrual bleeding

Current Illness

Preexisting Conditions

Other Medications

Previous Vaccinations

Allergies

Laboratory Data

Test Date: 20201221; Test Name: SARS-CoV-2 test; Test Result: Negative

Write-up

Uterine bleeding; period has not stopped; This is a spontaneous report from a contactable consumer or other non hcp downloaded from the Medicines Agency (MA) regulatory authority-WEB, regulatory authority number FR-AFSSAPS-RS20212684.
A 23-year-old female patient received bnt162b2 (COMIRNATY; Solution for injection, Lot Number: FE1573, Expiration Date was not reported), via intramuscular route of administration, administered in Arm Right on 29Jul2021 as dose 1, single for COVID-19 immunization.
The patient medical history and concomitant medications were not reported.
No history of COVID-19 reported.
On 30Jul2021 patient experienced uterine bleeding.
1 day post-vaccination, the patient states: "I started bleeding as if I had my period and since that day my period has not stopped.
I have had my period now, even though I had it a week before I was vaccinated and I am an extremely well-regulated person in terms of my periods.
I am not on the pill.
".
The patient underwent lab tests and procedures which included sars-cov-2 test was negative on 21Dec2020.
The outcome of events was not recovered.
No follow-up attempts are possible, no further information is expected.